CLINICAL_TRIALS
trial_result
· 2021-10-21
Clinical Trial Update: Triple Combination Therapy in High Risk Crohn's Disease (CD) [Phase 4]
Summary
Phase 4 clinical trial update for a triple combination therapy in high-risk Crohn's disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Takeda | Conditions: Crohn Disease | Phase 4 | Status: COMPLETED | Results posted: 2021-10-21